T cell exhaustion: from pathophysiological basics to tumor immunotherapy

被引:149
作者
Catakovic, Kemal [1 ,2 ]
Klieser, Eckhard [2 ,3 ]
Neureiter, Daniel [2 ,3 ]
Geisberger, Roland [1 ,2 ]
机构
[1] Paracelsus Med Univ, Ctr Oncol, Dept Internal Med Haematol Med Oncol Haemostaseol, Lab Immunol & Mol Canc Res, Mullner Hauptstr 48, A-5020 Salzburg, Austria
[2] Salzburg Canc Res Inst, Salzburg, Austria
[3] Paracelsus Med Univ, Dept Pathol, Mullner Hauptstr 48, A-5020 Salzburg, Austria
基金
奥地利科学基金会;
关键词
Immunotherapy; PD-1; PD-L1; T cell exhaustion; Cancer; LYMPHOCYTE-ACTIVATION GENE-3; NATURAL-KILLER-CELLS; VERSUS-HOST-DISEASE; NEGATIVE REGULATORY FUNCTION; DOSE-ESCALATION TRIAL; C VIRUS-INFECTION; OPEN-LABEL; CUTTING EDGE; B-LYMPHOCYTE; HEPATITIS-B;
D O I
10.1186/s12964-016-0160-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The immune system is capable of distinguishing between danger- and non-danger signals, thus inducing either an appropriate immune response against pathogens and cancer or inducing self-tolerance to avoid autoimmunity and immunopathology. One of the mechanisms that have evolved to prevent destruction by the immune system, is to functionally silence effector T cells, termed T cell exhaustion, which is also exploited by viruses and cancers for immune escape In this review, we discuss some of the phenotypic markers associated with T cell exhaustion and we summarize current strategies to reinvigorate exhausted T cells by blocking these surface marker using monoclonal antibodies.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 227 条
[1]   Reduced Tim-3 Expression on Human T-lymphotropic Virus Type I (HTLV-I) Tax-specific Cytotoxic T Lymphocytes in HTLV-I Infection [J].
Abdelbary, Nashwa H. ;
Abdullah, Hazem M. ;
Matsuzaki, Toshio ;
Hayashi, Daisuke ;
Tanaka, Yuetsu ;
Takashima, Hiroshi ;
Izumo, Shuji ;
Kubota, Ryuji .
JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (07) :948-959
[2]   A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer [J].
Aglietta, M. ;
Barone, C. ;
Sawyer, M. B. ;
Moore, M. J. ;
Miller, W. H., Jr. ;
Bagala, C. ;
Colombi, F. ;
Cagnazzo, C. ;
Gioeni, L. ;
Wang, E. ;
Huang, B. ;
Fly, K. D. ;
Leone, F. .
ANNALS OF ONCOLOGY, 2014, 25 (09) :1750-1755
[3]   Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression [J].
Albring, Joern C. ;
Sandau, Michelle M. ;
Rapaport, Aaron S. ;
Edelson, Brian T. ;
Satpathy, Ansuman ;
Mashayekhi, Mona ;
Lathrop, Stephanie K. ;
Hsieh, Chyi-Song ;
Stelljes, Matthias ;
Colonna, Marco ;
Murphy, Theresa L. ;
Murphy, Kenneth M. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (12) :2551-2559
[4]   2B4+ CD8+ T cells play an inhibitory role against constrained HIV epitopes [J].
Aldy, Kim N. ;
Horton, Nathan C. ;
Mathew, Porunelloor A. ;
Mathew, Stephen O. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 405 (03) :503-507
[5]  
Alegre ML, 1996, J IMMUNOL, V157, P4762
[6]   T-bet, a Th1 transcription factor regulates the expression of Tim-3 [J].
Anderson, Ana C. ;
Lord, Graham M. ;
Dardalhon, Valerie ;
Lee, David H. ;
Sabatos-Peyton, Catherine A. ;
Glimcher, Laurie H. ;
Kuchroo, Vijay K. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (03) :859-866
[7]   Progressive Loss of Memory T Cell Potential and Commitment to Exhaustion during Chronic Viral Infection [J].
Angelosanto, Jill M. ;
Blackburn, Shawn D. ;
Crawford, Alison ;
Wherry, E. John .
JOURNAL OF VIROLOGY, 2012, 86 (15) :8161-8170
[8]  
[Anonymous], WORLD C GI CANC 2016
[9]  
[Anonymous], 2012, J CLIN CELL IMMUNOL
[10]  
[Anonymous], JAMA J AM MED ASSOC